Cargando…

Non-Epithelial Ovarian Cancers: How Much Do We Really Know?

Non-epithelial ovarian cancers (NEOC) are a group of uncommon malignancies that mainly includes germ cell tumours (GCT), sex cord-stromal tumours (SCST), and some extremely rare tumours, such as small cell carcinomas and sarcomas. Each of these classifications encompasses multiple histologic subtype...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheung, Alison, Shah, Sidrah, Parker, Jack, Soor, Pavandeep, Limbu, Anu, Sheriff, Matin, Boussios, Stergios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834485/ https://www.ncbi.nlm.nih.gov/pubmed/35162125 http://dx.doi.org/10.3390/ijerph19031106

Ejemplares similares

Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
por: Shah, Sidrah, et al.
Publicado: (2022)

Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
por: Revythis, Antonios, et al.
Publicado: (2022)

Mobile phones in Africa: how much do we really know?
por: James, Jeffrey, et al.
Publicado: (2007)

Psychrotrophic bacteria in milk: How much do we really know?
por: de Oliveira, Gislene B., et al.
Publicado: (2015)

The Physiology of Bone Pain. How Much Do We Really Know?
por: Nencini, Sara, et al.
Publicado: (2016)

Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art
por: Boussios, Stergios, et al.
Publicado: (2023)

Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets
por: Ioannidou, Evangelia, et al.
Publicado: (2021)

Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
por: Shah, Sidrah, et al.
Publicado: (2021)

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
por: Lamon, Séverine, et al.
Publicado: (2013)

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
por: Boussios, Stergios, et al.
Publicado: (2022)

Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
por: Boussios, Stergios, et al.
Publicado: (2020)

Wise Management of Ovarian Cancer: On the Cutting Edge
por: Boussios, Stergios, et al.
Publicado: (2020)

Unraveling the Wide Spectrum of Melanoma Biomarkers
por: Revythis, Antonios, et al.
Publicado: (2021)

COVID-19 and cancer: do we really know what we think we know?
por: Robinson, Andrew G., et al.
Publicado: (2020)

Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
por: Ghose, Aruni, et al.
Publicado: (2021)

Multifocal Septic Arthritis Secondary to Infective Endocarditis: A Rare Case Report
por: Soor, Pavandeep, et al.
Publicado: (2017)

The Science of Soy: What Do We Really Know?
por: Barrett, Julia R.
Publicado: (2006)

Dark matter: what do we really know
por: Tao, C
Publicado: (2013)

Pyorrhea Alveolaris—What Do We Really Know of It
por: Trueman, W. H.
Publicado: (1897)

Lipoprotein (a)—We Know So Much Yet Still Have Much to Learn …
por: Banach, Maciej
Publicado: (2016)

Neglected Disease Research and Development: How Much Are We Really Spending?
por: Moran, Mary, et al.
Publicado: (2009)

Talus Visualization in Ankle Fractures: How Much Are We Really Seeing?
por: Hinckley, Nathaniel B., et al.
Publicado: (2022)

A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018)

Statin treatment in the elderly: how much do we know?
por: Rizzo, Manfredi, et al.
Publicado: (2013)

N-95 masks: how much do we know?
por: Bakshi, Satvinder Singh, et al.
Publicado: (2020)

Diversity in Neuroscience. We Know the Problem. Are We Really Still Debating the Solutions?
por: Weekes, Nicole Y.
Publicado: (2012)

What Do We Really Know About Neutron Stars?
por: Woltjer, Lodewijk
Publicado: (2003)

Childhood-onset schizophrenia: what do we really know?
por: Bartlett, Jennifer
Publicado: (2014)

Assembly and Turnover of Caveolae: What Do We Really Know?
por: Han, Bing, et al.
Publicado: (2016)

Cancer and COVID-19: what do we really know?
por: Poortmans, Philip M, et al.
Publicado: (2020)

Giant paraesophageal hernia: What do we really know?
por: Bhargava, Amit, et al.
Publicado: (2020)

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
por: Moschetta, Michele, et al.
Publicado: (2020)

Interplay of Cardiac and Cognitive Function: How Much Do We Really Understand?
Publicado: (2015)

Interplay of Cardiac and Cognitive Function: How Much Do We Really Understand?
por: Friedrich, Matthias G.
Publicado: (2015)

Real World Evidence: Can We Really Expect It to Have Much Influence?
por: Evans, Keith
Publicado: (2019)

Knowing Too Much
Publicado: (1887)

How Much They Know
Publicado: (1892)

Identity of tendon stem cells – how much do we know?
por: Lui, Pauline Po Yee
Publicado: (2013)

Deliberate use of placebos in clinical practice: what we really know
por: Harris, Cory S, et al.
Publicado: (2012)

Do we really know the duration of pain after rib fracture?
por: Tulay, Cumhur Murat, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5274cnneuoi57tol0n9047628q